Stoneridge Q3 Adjusted Sales Rise 29.9%, EBITDA Guidance at Prior Range Bottom

Q3 adjusted sales rose 29.9% year over year to $180.0 million, while adjusted EBITDA increased to $7.3 million from $5.2 million. Stoneridge recorded a $24.2 million arbitration-related charge and expects 2026 adjusted EBITDA at the bottom end of its prior expectations.